Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. United Natural Foods Plunges In Pre-market On Lower Profit Below View, Lowered Outlook
  2. Cryptos Muted As U.S. CPI Fails To Slide As Expected
  3. $BTC: Five Reasons Why Bitcoin Could Be a Better Store of Value Than Gold
  4. Hibbett Shares Rally On Better-than-estimated Earnings, Increased Outlook
  5. FREYR Battery Down 10% After Pricing Public Offering Of 20 Mln Shares